Human papillomavirus and nasopharyngeal cancer

Vivek Verma, Charles B. Simone, Chi Lin

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Background: There are no existing high-volume studies characterizing human papillomavirus (HPV)-associated nasopharyngeal cancer (NPC). Methods: The National Cancer Data Base (NCDB) was queried for NPC with known HPV (2004-2013). Logistic regression ascertained factors associated with HPV-positivity. Kaplan-Meier overall survival (OS) was evaluated between HPV-positive and HPV-negative cohorts; Cox proportional hazards modeling assessed factors associated with OS. Patients with nonmetastatic disease receiving definitive chemoradiotherapy underwent propensity-matched OS analysis. Results: Altogether, 956 patients were analyzed (32% HPV-positive and 68% HPV-negative). Median follow-up was 23 months (range 0-67 months). The patients with HPV-positive disease were younger, less likely to be uninsured, lived in more educated areas, and presented with more advanced T (but not N/overall) classification. Median OS for HPV-positive and HPV-negative groups were 50 and 43 months, respectively (P =.171). The HPV status did not independently predict for OS (P =.183). No OS differences were observed after propensity matching (P =.734). Conclusion: In what we believe as the only large study of HPV-associated NPC, HPV neither correlates with nor predicts survival in NPC. Owing to the difficulty of addressing causality in database studies, further work must corroborate the findings herein.

Original languageEnglish (US)
Pages (from-to)696-706
Number of pages11
JournalHead and Neck
Volume40
Issue number4
DOIs
StatePublished - Apr 1 2018

Fingerprint

Nasopharyngeal Neoplasms
Survival
Databases
Chemoradiotherapy
Survival Analysis
Causality

Keywords

  • chemotherapy
  • human papillomavirus
  • nasopharyngeal cancer
  • nasopharynx
  • radiotherapy

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Human papillomavirus and nasopharyngeal cancer. / Verma, Vivek; Simone, Charles B.; Lin, Chi.

In: Head and Neck, Vol. 40, No. 4, 01.04.2018, p. 696-706.

Research output: Contribution to journalArticle

Verma, Vivek ; Simone, Charles B. ; Lin, Chi. / Human papillomavirus and nasopharyngeal cancer. In: Head and Neck. 2018 ; Vol. 40, No. 4. pp. 696-706.
@article{31c3a9b914c64d9fabc120806e04b513,
title = "Human papillomavirus and nasopharyngeal cancer",
abstract = "Background: There are no existing high-volume studies characterizing human papillomavirus (HPV)-associated nasopharyngeal cancer (NPC). Methods: The National Cancer Data Base (NCDB) was queried for NPC with known HPV (2004-2013). Logistic regression ascertained factors associated with HPV-positivity. Kaplan-Meier overall survival (OS) was evaluated between HPV-positive and HPV-negative cohorts; Cox proportional hazards modeling assessed factors associated with OS. Patients with nonmetastatic disease receiving definitive chemoradiotherapy underwent propensity-matched OS analysis. Results: Altogether, 956 patients were analyzed (32{\%} HPV-positive and 68{\%} HPV-negative). Median follow-up was 23 months (range 0-67 months). The patients with HPV-positive disease were younger, less likely to be uninsured, lived in more educated areas, and presented with more advanced T (but not N/overall) classification. Median OS for HPV-positive and HPV-negative groups were 50 and 43 months, respectively (P =.171). The HPV status did not independently predict for OS (P =.183). No OS differences were observed after propensity matching (P =.734). Conclusion: In what we believe as the only large study of HPV-associated NPC, HPV neither correlates with nor predicts survival in NPC. Owing to the difficulty of addressing causality in database studies, further work must corroborate the findings herein.",
keywords = "chemotherapy, human papillomavirus, nasopharyngeal cancer, nasopharynx, radiotherapy",
author = "Vivek Verma and Simone, {Charles B.} and Chi Lin",
year = "2018",
month = "4",
day = "1",
doi = "10.1002/hed.24978",
language = "English (US)",
volume = "40",
pages = "696--706",
journal = "Head and Neck",
issn = "1043-3074",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - Human papillomavirus and nasopharyngeal cancer

AU - Verma, Vivek

AU - Simone, Charles B.

AU - Lin, Chi

PY - 2018/4/1

Y1 - 2018/4/1

N2 - Background: There are no existing high-volume studies characterizing human papillomavirus (HPV)-associated nasopharyngeal cancer (NPC). Methods: The National Cancer Data Base (NCDB) was queried for NPC with known HPV (2004-2013). Logistic regression ascertained factors associated with HPV-positivity. Kaplan-Meier overall survival (OS) was evaluated between HPV-positive and HPV-negative cohorts; Cox proportional hazards modeling assessed factors associated with OS. Patients with nonmetastatic disease receiving definitive chemoradiotherapy underwent propensity-matched OS analysis. Results: Altogether, 956 patients were analyzed (32% HPV-positive and 68% HPV-negative). Median follow-up was 23 months (range 0-67 months). The patients with HPV-positive disease were younger, less likely to be uninsured, lived in more educated areas, and presented with more advanced T (but not N/overall) classification. Median OS for HPV-positive and HPV-negative groups were 50 and 43 months, respectively (P =.171). The HPV status did not independently predict for OS (P =.183). No OS differences were observed after propensity matching (P =.734). Conclusion: In what we believe as the only large study of HPV-associated NPC, HPV neither correlates with nor predicts survival in NPC. Owing to the difficulty of addressing causality in database studies, further work must corroborate the findings herein.

AB - Background: There are no existing high-volume studies characterizing human papillomavirus (HPV)-associated nasopharyngeal cancer (NPC). Methods: The National Cancer Data Base (NCDB) was queried for NPC with known HPV (2004-2013). Logistic regression ascertained factors associated with HPV-positivity. Kaplan-Meier overall survival (OS) was evaluated between HPV-positive and HPV-negative cohorts; Cox proportional hazards modeling assessed factors associated with OS. Patients with nonmetastatic disease receiving definitive chemoradiotherapy underwent propensity-matched OS analysis. Results: Altogether, 956 patients were analyzed (32% HPV-positive and 68% HPV-negative). Median follow-up was 23 months (range 0-67 months). The patients with HPV-positive disease were younger, less likely to be uninsured, lived in more educated areas, and presented with more advanced T (but not N/overall) classification. Median OS for HPV-positive and HPV-negative groups were 50 and 43 months, respectively (P =.171). The HPV status did not independently predict for OS (P =.183). No OS differences were observed after propensity matching (P =.734). Conclusion: In what we believe as the only large study of HPV-associated NPC, HPV neither correlates with nor predicts survival in NPC. Owing to the difficulty of addressing causality in database studies, further work must corroborate the findings herein.

KW - chemotherapy

KW - human papillomavirus

KW - nasopharyngeal cancer

KW - nasopharynx

KW - radiotherapy

UR - http://www.scopus.com/inward/record.url?scp=85040585882&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85040585882&partnerID=8YFLogxK

U2 - 10.1002/hed.24978

DO - 10.1002/hed.24978

M3 - Article

VL - 40

SP - 696

EP - 706

JO - Head and Neck

JF - Head and Neck

SN - 1043-3074

IS - 4

ER -